Escitalopram and Language Intervention for Subacute Aphasia

ConditionsAphasiaStroke
Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18-99
SponsorJohns Hopkins University

About this trial

In this project, the investigators will investigate the effects of a selective serotonin reuptake inhibitor (SSRI), escitalopram, on augmenting language therapy effectiveness, as measured by naming untrained pictures and describing pictures, in individuals with aphasia in the acute and subacute post stroke period (i.e., within three months post stroke).

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Participants must have sustained an acute ischemic left hemisphere stroke.

Participants must be fluent speakers of English by self-report.

Participants must be capable of giving informed consent or indicating a legally authorized representative to provide informed consent.

Participants must be age 18 or older.

Disqualifiers

Previous neurological disease affecting the brain including previous symptomatic stroke

Diagnosis of schizophrenia, autism, or other psychiatric or neurological condition that affects naming/language

A history of additional risk factors for torsades de pointes (TdP; e.g., heart failure, hypokalemia, family history of Long QT Syndrome)

Current severe depression, defined as a score of > 15 on the Patient Health Questionnaire (PHQ-9)

Trial design

Design model

Parallel

Treatments tested in this trial

  • Escitalopram 10mg

    Drug

    Escitalopram tablet

  • Placebo

    Drug

    Sugar pill manufactured to mimic escitalopram 10 mg tablet

  • Computer-delivered naming treatment

    Behavioral

    15 45-minute sessions of computer-delivered naming treatment beginning two months following stroke

Treatment groups

88 Participants
are divided into 2 treatment groups
Group A: Naming Treatment + EscitalopramExperimental treatment 2 interventions
Group B: Naming Treatment + PlaceboPlacebo comparator 2 interventions

Trial outcomes

Primary outcomes

1

Change in Philadelphia Naming Test short-form accuracy score

Number of correctly named items of 30 total items on the computerized picture naming assessment. Scores ranges from 0 to 30 with higher scores meaning better naming ability.

Time frame
Baseline, 1 week after computer-delivered naming treatment

Secondary outcomes

1

Language production as assessed by lexical features of discourse in "Cookie Theft" picture description

Lexical features, meaning carrying units of language (morphemes), will be counted for each Cookie Theft picture description. There is no maximum number of meaning carrying units, but norms are available to assist in the interpretation of this performance.

Time frame
Baseline, 5 weeks after computer-delivered naming treatment
2

Language production as assessed by content units included in picture description of "Cookie Theft"

Content units are based on a standard scoring template of commonly identified concepts (nouns and verbs) in the left and right regions of the "Cookie Theft" picture. Participants either include or fail to include 30 concepts on the left side of the picture and 23 concepts on the right side of the picture. A ratio of included left content units to included right content units then can be calculated and interpreted as a measure of hemispatial attention.

Time frame
Baseline, 5 weeks after computer-delivered naming treatment
3

Language production as assessed by rate of syllables per content unit produced in "Cookie Theft" picture description

Syllables included in the picture description are counted. Content units are based on a standard scoring template of commonly identified concepts (nouns and verbs) in the left and right regions of the "Cookie Theft" picture. Participants either include or fail to include 30 concepts on the left side of the picture and 23 concepts on the right side of the picture. The average rate of syllables per content unit produced can then be calculated and interpreted as a measure of efficiency in producing relevant information in the task.

Time frame
Baseline, 5 weeks after computer-delivered naming treatment
4

Depression as assessed by Patient Health Questionnaire (PHQ-9)

9 item scale scored 0-3 for each item. PHQ-9 scores of 5, 10, 15, and 20 represent mild, moderate, moderately severe, and severe depression. PHQ-9 \>15 or suicidal ideation suggest depression sufficient for exclusion or removal from study.

Time frame
Baseline, 1 week after computer-delivered naming treatment

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Johns Hopkins University

Lead sponsor

University of South Carolina

Collaborator

Medical University of South Carolina

Collaborator

University of California, Irvine

Collaborator

National Institute on Deafness and Other Communication Disorders (NIDCD)

Collaborator